We have been contacted by several of our supporters who raised concerns about the availability of EpiPen® in the UK. We have contacted Mylan who distribute EpiPen® in the UK for clarification who have have provided us with a statement, which is below.
EpiPen® is an adrenaline auto-injector used for the emergency treatment of severe allergic reactions known as anaphylaxis and is a prescription only medicine. The Anaphylaxis Campaign is in continuous dialogue with the distributors of adrenaline auto-injectors in the UK and we will continue to keep you updated about supply issues.
If you have any concerns please speak to Mylan customer services on +44 (0)1707 853 100 and contact our helpline and information team at [email protected] or call 01252 542 029 for support.
Availability of EpiPen® (Senior) 0.3mg Adrenaline Auto-Injector
Due to manufacturing delays from our contract manufacturer, Meridian Medical Technologies, a Pfizer company, there are intermittent supply constraints of EpiPen® 0.3mg (Senior) Adrenaline Auto-Injector in the UK. At this time, there are no supply constraints of EpiPenJr® 0.15mg Adrenaline Auto-Injectors.
Our first priority is to ensure patients at risk for a potentially life-threatening allergic reaction (anaphylaxis) have access to adrenaline auto-injector products. Mylan is working closely with Pfizer to manage supply carefully to avoid long-term supply shortages. Pfizer anticipates that production rates will increase over the coming months; however, at this time, cannot commit to a specific time for when the supply constraint will be fully resolved.
Mylan is unable to make any specific treatment recommendation to individual patients. Patients should speak to their healthcare provider for appropriate actions to be taken. Please note, when validating the expiry date of an adrenaline auto-injector, the product expires on the last day of the month indicated. For example, if it expires in March, it remains valid (not expired) until March 31.
If you require additional information or have any questions, please contact +44(0) 1707 853 100.